dermatomyositis

GPTKB entity

Statements (52)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:rituximab
gptkb:azathioprine
gptkbp:affects gptkb:skincare_product
muscles
gptkbp:associated_with gptkb:healthcare_organization
gptkbp:characteristics fatigue
weight loss
fever
joint pain
difficulty swallowing
Gottron's papules
heliotrope rash
muscle inflammation
gptkbp:complications gptkb:healthcare_organization
dysphagia
calcinosis
gptkbp:current_use gptkb:systemic_lupus_erythematosus
gptkb:motorcycle
polymyositis
mixed connective tissue disease
gptkbp:gender gptkb:philosopher
male
https://www.w3.org/2000/01/rdf-schema#label dermatomyositis
gptkbp:is_popular_in rare
gptkbp:premiered_on childhood
adulthood
gptkbp:research_focus genetic factors
treatment efficacy
environmental triggers
pathogenesis
gptkbp:risk_factor stress
age
family history
smoking
gender
sunlight exposure
certain infections
exposure to certain drugs
gptkbp:social_responsibility gptkb:MRI
variable
blood tests
chronic
more common in adults
muscle biopsy
more common in children
potentially life-threatening
gptkbp:symptoms muscle weakness
skin rash
gptkbp:treatment corticosteroids
immunosuppressants